NEW YORK (GenomeWeb) – Agilent Technologies has announced a co-marketing agreement with contract research organization PureHoney Technologies to develop new applications on the RapidFire 365 High-throughput Mass Spectrometry System.

Under the terms of the agreement, the partners will work both together and independently on new workflows for pharmaceutical-focused research, forensic toxicology, and metabolomics analysis. RapidFire technology provides label-free, high-throughput screening for several applications.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers are refining a tool to predict a woman's risk of developing breast cancer, according to the Guardian.

According to Stat News, the partial government shutdown in the US could soon affect the ability of the Food and Drug Administration to review new drugs.

In PNAS this week: gypsy moth genome sequenced, phylogenomic analysis of Polyneopterans, and more.

CNN reports that people's genes tend to have a greater influence on their risk of developing disease than their environment, but it varies by phenotype.